Also found in: Wikipedia.
MEDCOMiddle East Dredging Company (Qatar)
MEDCOMindanao Economic Development Council (Philippines)
MEDCOMedische Compagnie (Dutch)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
pharmacy benefit management market share Pre-merger CVS Caremark 20% Medco 15% Express Scripts/WellPoint 17% Argus Health Systems 13% UNH's OptumRx 12% Catalyst Rx 5% SXC Solutions (NMHC) 2% Others 16% Post-merger CVS Caremark 20% Express Scripts/Medco 32% Argus Health Systems 13% UNH's OptumRx 12% Catalyst Rx 5% SXC Solutions (NMHC) 2% Others 16% Sources: AIS Health, IMS Health and William Blair & Co.
29 June 2011 -- S&P today confirmed its B long-term corporate credit rating with a "negative" outlook on Indonesian oil and gas exploration and production firm PT Medco Energi Internasional Tbk (JAK:MEDC).
PT Medco Energi Internasionala estimates its oil and gas explorations in Libya will cost up to US$600 million, a company executive said.
The surge in the oil prices boosted Medco and became more aggressive in expanding business in the oil sector.
Under the new deal, Ophir said Jakarta-listed Medco has until January 28 to make a firm offer."The Boards of Ophir and Medco confirm they are in discussions about a possible cash offer to be made by Medco for the entire issued share capital of Ophir," said Ophir in a statement.
However, Medco's ratings will continue to be on Positive Outlook until we receive more clarity on the final terms of the proposed price revision and potential regulatory mechanisms to compensate for the resultant revenue losses.
Established in 1996, Medco Plast is a leading manufacturer of PET preforms, injection moulded products and closures for local and multinational clients, primarily in the carbonated soft drinks, bottled water and dairy segments.
MEG and Samaha family, which are the primary shareholders, will retain 16% and 10% shares in Medco Plast respectively.
and Xu Hanjiang, Medco said in a disclosure to the Philippine Stock Exchange.
MedCo Data has been servicing the automation and billing needs of dermatologists and other single specialty groups throughout the US.
MedCo's form of bivalirudin is prepared using an improved compounding process that reduces the formation of impurities--that otherwise render the drug unusable for human injection--to less than 0.6%.